Xeris atinge novo máximo em 52 semanas, já que a meta de receita para 2030 ultrapassa US$ 1 bilhão

Xeris Pharmaceuticals (XERS) stock hits a 52-week high as the company posts better than expected financials and raises its outlook. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real